# UNIVFY

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/univfy

- Industry: Healthcare IT
- Headquarters: Los Altos, US
- Website: www.univfy.com
- Total disclosed funding: $12M
- Latest round: Series B (Dec 20, 2021)
- Investors on record: 2

## About

UNIVFY Inc. specializes in revolutionizing the fertility treatment landscape through innovative data-driven insights and personalized solutions to enhance patient experiences and outcomes.Founded in 2009 in Los Altos, California, UNIVFY Inc. focuses on providing advanced tools for fertility treatments. Mylene Yao serves as both the Founder and CEO, guiding the company through its strategic initiatives. The company has completed a total of 4 funding deals, with the latest being a Series B round raised in December 2021, amounting to USD 6.000 mn, led by Atlantic Street Capital. UNIVFY's current valuation stands at USD 34.800 mn.UNIVFY offers a suite of innovative products aimed at enhancing the fertility treatment experience through data-driven insights and personalized solutions. Their flagship product, the Univfy PreIVF Report, provides individualized success probability assessments for IVF, tailored to each patient's unique circumstances and reproductive history. This offering empowers users to make informed decisions in collaboration with their fertility specialists. Additionally, the company assists fertility centers in creating financial programs such as IVF refund and multi-cycle discounts, reducing the financial risks associated with fertility treatments. UNIVFY serves a diverse clientele, including individuals and couples seeking fertility assistance, as well as numerous fertility clinics in the United States, Canada, and several European markets.UNIVFY generates revenue primarily through partnerships with fertility clinics and healthcare providers, offering subscription-based access to their AI-driven reporting platform. Clinics utilize the Univfy PreIVF Report to provide customized success predictions, thereby driving patient engagement and clinic success metrics. The financial model often involves revenue-sharing agreements, wherein clinics are charged a fee for each report generated for patients. Moreover, fertility specialists in the UNIVFY Network can participate in refund programs that incentivize streamlined treatments, thus attracting more patients seeking financial guarantees. Pricing models are tailored for clinics based on their size and report generation volume, ensuring accessibility while aligning with operational goals.The recent Series B funding round of USD 6.000 mn, raised in December 2021, will support UNIVFY's strategy to expand its fertility benefits and advance fertility prognostics. The company is focusing on developing new products designed to enhance their current offerings and plans to expand into additional markets both domestically and internationally. Specific geographic regions targeted for growth have not been disclosed, but the company is actively pursuing opportunities to reach more fertility clinics and patients. Through these strategic efforts, UNIVFY aims to solidify its presence in the fertility treatment industry.

## Funding rounds

- Series B, Dec 20, 2021, $6M — Atlantic Street Capital
- Series A, Feb 6, 2018, $6M — Rethink Capital Partners

## Investors

- Rethink Capital Partners (https://capitalatlas.ai/funds/rethink-capital-partners) — Series A
- Atlantic Street Capital (https://capitalatlas.ai/funds/atlantic-street-capital) — Series B